A randomized phase II study of Taxotere versus doxorubicin in first and second line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults.
2000-01-01 2, 4. Verweij J.; Lee, S. M.; Ruka, W.; Buesa, J.; Coleman, R.; van Hoesel, R.; Seynaeve, C.; Donato Di Paola, E; Van glabbeke, M.; Locci-tonelli, D.; Judson, I.
Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.
2018-01-01 IeDEA and COHERE Cohort, Collaborations; Torti, C
Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts
2009-01-01 Torti, C; Lapadula, G; Antinori, A; Quirino, T; Maserati, R; Castelnuovo, F; Maggiolo, F; De Luca, A; Paraninfo, G; Antonucci, F; Migliorino, G; Lazzarin, A; Di Perri, G; Rizzardini, G; Esposito, R; Carosi, G
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications
2010-01-01 Torti, C; Lapadula, G; Izzo, I; Brindicci, G; Labbate, G; Quiros-Roldan, E; Diallo, I; Gargiulo, F; Castelnuovo, F; Calabresi, A; Carosi, G; Manca, N; Monno, L
Cryptogenic Liver Diseases: Sailing by Sight from HIV Co-Infection with Hepatitis Viruses to HIV Mono-Infection Through the Pillars of Hercules
2011-01-01 Gotti, D; Foca, E; Albini, L; Mendeni, M; Vavassori, A; Roldan, Eq; Torti, C
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008
2011-01-01 Prosperi, Mcf; Cozzi-Lepri, A; Antinori, A; Cassola, G; Torti, C; Ursitti, Ma; Pellizzer, Gp; Giacometti, A; Monforte, Ad; De Luca, A
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy
2011-01-01 Pavie, J; Porcher, R; Torti, C; Medrano, J; Castagna, A; Valin, N; Rusconi, S; Ammassari, A; Ghosn, J; Delaugerre, C; Molina, Jm
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz
2012-01-01 Foca, E; Motta, D; Borderi, M; Gotti, D; Albini, L; Calabresi, A; Izzo, I; Bellagamba, R; Narciso, P; Sighinolfi, L; Clo, A; Gibellini, D; Quiros-Roldan, E; Brianese, N; Cesana, Bm; Re, Mc; Torti, C
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010
2012-01-01 Colafigli, M; Torti, C; Albini, L; Rosi, A; Micheli, V; Manca, N; Penco, G; Bruzzone, B; Punzi, G; Corsi, P; Parruti, G; Bagnarelli, P; Monno, L; Gonnelli, A; Cauda, R; Di Giambenedetto, S; Trecarichi, E
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
2013-01-01 Raffi, F; Rachlis, A; Stellbrink, Hj; Hardy, Wd; Torti, C; Orkin, C; Bloch, M; Podzamczer, D; Pokrovsky, V; Pulido, F; Almond, S; Margolis, D; Brennan, C; Min, S
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe
2013-01-01 De Luca, A; Dunn, D; Zazzi, M; Camacho, R; Torti, C; Fanti, I; Kaiser, R; Sonnerborg, A; Codoner, Fm; Van Laethem, K; Vandamme, Am; Bansi, L; Ghisetti, V; van de Vijver, Damc; Asboe, D; Prosperi, Mcf; Di Giambenedetto, S
In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components
2012-01-01 Furneri, Pm; Mondello, L; Mandalari, G; Paolino, D; Dugo, P; Garozzo, A; Bisignano, G
Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes
2013-01-01 Marianecci, C; Rinaldi, F; Di Marzio, L; Pozzi, D; Caracciolo, G; Manno, D; Dini, L; Paolino, D; Celia, C; Carafa, M
Niosomes from 80s to present: The state of the art
2014-01-01 Marianecci, C; Di Marzio, L; Rinaldi, F; Celia, C; Paolino, D; Alhaique, F; Esposito, S; Carafa, M
Influence of the Supramolecular Micro-Assembly of Multiple Emulsions on their Biopharmaceutical Features and In vivo Therapeutic Response
2015-01-01 Cilurzo, F; Cristiano, Mc; Di Marzio, L; Carafa, M; Ventura, Ca; Paolino, D; Fresta, M; Cosco, D
PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity
2016-01-01 De Rose, Rf; Cristiano, Mc; Celano, M; Maggisano, V; Vero, A; Lombardo, Ge; Di Francesco, M; Paolino, D; Cosco, D; Russo, D
A MINIREVIEW ABOUT PRETERM BIRTH AND MAIN SPECIFIC NEURODEVELOPMENTAL DISORDERS
2018-01-01 Maltese, a cerroni f; Romano, P; Russo, D; Salerno, M; Gallai, B; Marotta, R; Lavano, Sm; Lavano, F; Tripi, G.
La Carta UE dei diritti fondamentali fa gola o fa paura? Intervista in tre domande, 23-27 aprile 2019
2019-01-01 Mori, P
L'uso della procedura di infrazione a fronte di violazioni dei diritti fondamentali
2018-01-01 Mori, P
Human brain injury and mirnas: An experimental study
2019-01-01 Sessa, F; Maglietta, F; Bertozzi, G; Salerno, M; Messina, G; Montana, A; Ricci, P; Pomara, C; Di Mizio, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A randomized phase II study of Taxotere versus doxorubicin in first and second line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults. | 1-gen-2000 | 2, 4. Verweij J.; Lee, S. M.; Ruka, W.; Buesa, J.; Coleman, R.; van Hoesel, R.; Seynaeve, C.; Donato Di Paola, E; Van glabbeke, M.; Locci-tonelli, D.; Judson, I. | |
| Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. | 1-gen-2018 | IeDEA and COHERE Cohort, Collaborations; Torti, C | |
| Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts | 1-gen-2009 | Torti, C; Lapadula, G; Antinori, A; Quirino, T; Maserati, R; Castelnuovo, F; Maggiolo, F; De Luca, A; Paraninfo, G; Antonucci, F; Migliorino, G; Lazzarin, A; Di Perri, G; Rizzardini, G; Esposito, R; Carosi, G | |
| Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications | 1-gen-2010 | Torti, C; Lapadula, G; Izzo, I; Brindicci, G; Labbate, G; Quiros-Roldan, E; Diallo, I; Gargiulo, F; Castelnuovo, F; Calabresi, A; Carosi, G; Manca, N; Monno, L | |
| Cryptogenic Liver Diseases: Sailing by Sight from HIV Co-Infection with Hepatitis Viruses to HIV Mono-Infection Through the Pillars of Hercules | 1-gen-2011 | Gotti, D; Foca, E; Albini, L; Mendeni, M; Vavassori, A; Roldan, Eq; Torti, C | |
| Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008 | 1-gen-2011 | Prosperi, Mcf; Cozzi-Lepri, A; Antinori, A; Cassola, G; Torti, C; Ursitti, Ma; Pellizzer, Gp; Giacometti, A; Monforte, Ad; De Luca, A | |
| Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy | 1-gen-2011 | Pavie, J; Porcher, R; Torti, C; Medrano, J; Castagna, A; Valin, N; Rusconi, S; Ammassari, A; Ghosn, J; Delaugerre, C; Molina, Jm | |
| Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz | 1-gen-2012 | Foca, E; Motta, D; Borderi, M; Gotti, D; Albini, L; Calabresi, A; Izzo, I; Bellagamba, R; Narciso, P; Sighinolfi, L; Clo, A; Gibellini, D; Quiros-Roldan, E; Brianese, N; Cesana, Bm; Re, Mc; Torti, C | |
| Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 | 1-gen-2012 | Colafigli, M; Torti, C; Albini, L; Rosi, A; Micheli, V; Manca, N; Penco, G; Bruzzone, B; Punzi, G; Corsi, P; Parruti, G; Bagnarelli, P; Monno, L; Gonnelli, A; Cauda, R; Di Giambenedetto, S; Trecarichi, E | |
| Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study | 1-gen-2013 | Raffi, F; Rachlis, A; Stellbrink, Hj; Hardy, Wd; Torti, C; Orkin, C; Bloch, M; Podzamczer, D; Pokrovsky, V; Pulido, F; Almond, S; Margolis, D; Brennan, C; Min, S | |
| Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe | 1-gen-2013 | De Luca, A; Dunn, D; Zazzi, M; Camacho, R; Torti, C; Fanti, I; Kaiser, R; Sonnerborg, A; Codoner, Fm; Van Laethem, K; Vandamme, Am; Bansi, L; Ghisetti, V; van de Vijver, Damc; Asboe, D; Prosperi, Mcf; Di Giambenedetto, S | |
| In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components | 1-gen-2012 | Furneri, Pm; Mondello, L; Mandalari, G; Paolino, D; Dugo, P; Garozzo, A; Bisignano, G | |
| Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes | 1-gen-2013 | Marianecci, C; Rinaldi, F; Di Marzio, L; Pozzi, D; Caracciolo, G; Manno, D; Dini, L; Paolino, D; Celia, C; Carafa, M | |
| Niosomes from 80s to present: The state of the art | 1-gen-2014 | Marianecci, C; Di Marzio, L; Rinaldi, F; Celia, C; Paolino, D; Alhaique, F; Esposito, S; Carafa, M | |
| Influence of the Supramolecular Micro-Assembly of Multiple Emulsions on their Biopharmaceutical Features and In vivo Therapeutic Response | 1-gen-2015 | Cilurzo, F; Cristiano, Mc; Di Marzio, L; Carafa, M; Ventura, Ca; Paolino, D; Fresta, M; Cosco, D | |
| PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity | 1-gen-2016 | De Rose, Rf; Cristiano, Mc; Celano, M; Maggisano, V; Vero, A; Lombardo, Ge; Di Francesco, M; Paolino, D; Cosco, D; Russo, D | |
| A MINIREVIEW ABOUT PRETERM BIRTH AND MAIN SPECIFIC NEURODEVELOPMENTAL DISORDERS | 1-gen-2018 | Maltese, a cerroni f; Romano, P; Russo, D; Salerno, M; Gallai, B; Marotta, R; Lavano, Sm; Lavano, F; Tripi, G. | |
| La Carta UE dei diritti fondamentali fa gola o fa paura? Intervista in tre domande, 23-27 aprile 2019 | 1-gen-2019 | Mori, P | |
| L'uso della procedura di infrazione a fronte di violazioni dei diritti fondamentali | 1-gen-2018 | Mori, P | |
| Human brain injury and mirnas: An experimental study | 1-gen-2019 | Sessa, F; Maglietta, F; Bertozzi, G; Salerno, M; Messina, G; Montana, A; Ricci, P; Pomara, C; Di Mizio, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista24026
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa19
- 2020 - 20268915
- 2010 - 20198783
- 2000 - 20093805
- 1990 - 19991818
- 1980 - 1989642
- 1973 - 197945
Editore
- Academic Press, Elsevier2
- Elsevier2
- Wiley-Blackwell2
- Betham Science Publishers Ltd1
- EDIZIONI MINERVA MEDICA1
- Elsevier Ltd1
- Frontiers Media S.A.1
- Harold H. Trimm, Willam Hunter1
- ieee1
- Morgan Kaufmann1
Rivista
- JOURNAL OF CLINICAL MEDICINE240
- INTERNATIONAL JOURNAL OF MOLECULA...192
- PLOS ONE183
- NUTRIENTS137
- EPILEPSIA127
- CANCERS116
- SCIENTIFIC REPORTS113
- THE JOURNAL OF CLINICAL ENDOCRINO...103
- NEUROLOGICAL SCIENCES95
- NEUROLOGY91
Keyword
- Humans1115
- Female551
- Male482
- COVID-19345
- Aged329
- Middle Aged314
- Adult282
- Italy201
- SARS-CoV-2176
- Treatment Outcome153
Lingua
- eng18184
- ita2590
- spa48
- fre31
- ger24
- und9
- por2
- rus2
- aze1
- bos1
Accesso al fulltext
- no fulltext23991
- reserved26
- open10